30-09-2026 16:00 via medpagetoday.com

Why Earlier Conversations About Long-Acting Injectables for Schizophrenia Matter

(MedPage Today) -- Bryce Reynolds, MD, at Carolina Outreach is a paid partner of Teva Pharmaceuticals.
One of the biggest paradoxes in schizophrenia care is that some of our most established treatment options are still among the least utilized...
Read more »

Medical Industry news



Epic Fail: Robots Don't Improve Joint Replacement Outcomes in Big U.K. Studies
New Easier-to-Use GLP-1 Pill Safe for the Heart, Study Says
SERD Combination Slows Breast Cancer After CDK4/6 Inhibitor Progression
Who Should Manage a Hospital Cyberattack?
Unexpected Lack of Survival Benefit in Liver Cancer Treated With Proton Therapy
Senate Committee Advances Surgeon General Nominee
No Clear Risks With GLP-1s Around Pregnancy, but Caution Urged
These Specialties Had the Highest Starting Salaries This Year
VA's New Antidepressant Rules; App Aids Schizophrenia; Diet and Depression
Sepsis in Pregnancy Is a Deadly Combo: Here's Who's at Risk
Safe and Effective Therapies for Unfit Elderly Patients With DLBCL
Treatment Strategies for Richter's Transformation to DLBCL Are Evolving
Poll: Rural MAHA Followers Say Trump Hasn't Improved Health of Their Communities
CDC Raises Measles Death Count Again; MAHA Summit Takeaways; Kennedy's Vax AI Plans
Desktop versie